The scale-X™ cell collect module has been designed to overcome these challenges, resulting in a reduced aseptic risk, and a decrease in costs, footprint, and operational time, coupled with high reproducibility.
Read article "New benchtop seed train system overcomes bottlenecks of advanced therapy large-scale manufacture"Product news
The scale-X bioreactor is an intensified and chained bioprocessing platform for viral developers and manufacturers. It multiplies product yield and reduces operational volumes per cleanroom surface area compared to traditional technology.
Read article "scale-X™ bioreactor demonstrates superior productivity for vaccines and gene therapy"
Launched in April 2019, The scale-X™ carbo is an intermediate scale system designed for rapid process development and GMP manufacturing
Read article "Going from process development to clinical manufacturing has never been so easy"
New generation NevoLine™ platform for intensified & automated virus manufacturing
Read article "The NevoLine™ Upstream Platform for intensified & automated virus manufacturing"
The scale-X™ bioreactor range and the NevoLine™ platform for an intensified AAV and Lentiviral vectors manufacturing
Read article "Building capacity for gene therapy production"
Bench-scale automated cell culture system featuring the scale-X single-use fixed-bed bioreactor offering 10 to 30 m² growth surface.
Read article "Introducing the single-use scale-X™ carbo bioreactor system"
Univercells and consortium partner Batavia Biosciences have been awarded a $4 million grant extension by the Bill & Melinda Gates Foundation to scale up their low-cost polio vaccine manufacturing technology.
Read article "Introducing the NevoLine™ sIPV platform"